Kolexia
Carrie Nathalie Gastro-entérologie
Carrie Nathalie
Gastro-entérologie
Hôpital Jean Verdier
Bondy, France
219 Activités
3 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinome hépatocellulaire Carcinomes Tumeurs du foie Fibrose Cirrhose du foie Hépatite Maladies du foie Hépatite C Hypertension portale

Collaborateurs

Voir plus
Nahon Pierre
Nahon Pierre
Hôpital Jean Verdier, Bondy, France
Nault Jean-Charles
Nault Jean-Charles
Hôpital Jean Verdier, Bondy, France
Ziol Marianne
Ziol Marianne
Hôpital Avicenne, Bobigny, France
De Ledinghen Victor
De Ledinghen Victor
Hôpital Haut-lévêque, Pessac, France

Industries

Voir plus
Gilead
34 collaboration(s)
Dernière en 2023
Abbvie
5 collaboration(s)
Dernière en 2023
A+A
4 collaboration(s)
Dernière en 2023
Ipsen
2 collaboration(s)
Dernière en 2020

Dernières activités

Voir plus
Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma.
Liver international : official journal of the International Association for the Study of the Liver   04 mars 2024
Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma.
Radiology   28 février 2024
Incidence and clinical impact of bile ducts changes after multibipolar radiofrequency ablation for hepatocellular carcinoma.
European radiology   09 février 2024
Virological and clinical outcomes of patients with HDV-related compensated cirrhosis treated with Bulevirtide monotherapy for 96 weeks: a retrospective multicenter european study (SAVE-D)
Abstracts of the 56th A.I.S.F. - Italian Association for theStudy of the Liver - Annual Meeting 2024Rome, March 14th -15th, 2024   01 février 2024
Bulevirtide monotherapy prevents liver decompensation and reduces mortality in patients with HDV-related cirrhosis: a case control study with propensity score weighted analysis
Abstracts of the 56th A.I.S.F. - Italian Association for theStudy of the Liver - Annual Meeting 2024Rome, March 14th -15th, 2024   01 février 2024
No correlation between MASLD and poor outcome of Atezolizumab-Bevacizumab therapy in patients with advanced HCC.
Liver international : official journal of the International Association for the Study of the Liver   30 janvier 2024
Atezolizumab and bevacizumab for non-resectable or metastatic combined hepatocellular-cholangiocarcinoma: A multicentric retrospective study.
United European gastroenterology journal   07 décembre 2023
Impact of radiological response and pattern of progression in patients with hepatocellular carcinoma treated by atezolizumab- bevacizumab.
Hepatology (Baltimore, Md.)   23 octobre 2023
The clinical and financial burden of nonhepatocellular carcinoma focal lesions detected during surveillance of patients with cirrhosis.
Hepatology (Baltimore, Md.)   29 septembre 2023
International survey among hepatologists and pulmonologists on the hepatic hydrothorax: plea for recommendations.
BMC gastroenterology   12 septembre 2023